Permanent Makeup in Dermatology: New Report Reviews Techniques, Regulations, and Risks

June 18, 2024

AA Pipeline Update: Equillium’s EQ101 Shows Promise in Phase 2 Trial

June 5, 2024

Soterios Pharma’s STS-01 Meets Efficacy Endpoints in AA Trial

May 31, 2024

Mount Sinai Awarded $6.6M NIH Grant to Study Dupilumab in Pediatric AA

May 16, 2024

Drug-delivering Microneedle Patch May Spur Hair Regrowth in AA

May 9, 2024

Study: Stigma Affects Quality of Life for Kids With Chronic Skin Diseases

April 24, 2024

Topical Vs. Oral Minoxidil: What’s the Difference for Men With Androgenetic Alopecia?

April 15, 2024

Real-world Data: AA Patients Report Unmet Needs, High Disease Burden

March 8, 2024

Pelage Pharmaceuticals Announces $16.75M Series A Financing to Advance Hair Loss Treatment

February 27, 2024

Oh, The Places Dermatology Will Go in 2024!

February 8, 2024

AA Pipeline Watch: Sun Pharma’s Deuruxolitinib Performs Well in New Phase 3 Data

January 23, 2024

COVID-19 Infection May Up Alopecia Risk

January 10, 2024